332 related articles for article (PubMed ID: 10197038)
1. Recent developments in streptogramin research.
Barrière JC; Berthaud N; Beyer D; Dutka-Malen S; Paris JM; Desnottes JF
Curr Pharm Des; 1998 Apr; 4(2):155-80. PubMed ID: 10197038
[TBL] [Abstract][Full Text] [Related]
2. Streptogramins - two are better than one!
Mast Y; Wohlleben W
Int J Med Microbiol; 2014 Jan; 304(1):44-50. PubMed ID: 24119565
[TBL] [Abstract][Full Text] [Related]
3. Novel streptogramin antibiotics.
Bonfiglio G; Furneri PM
Expert Opin Investig Drugs; 2001 Feb; 10(2):185-98. PubMed ID: 11178336
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of streptogramins and macrolides.
Vannuffel P; Cocito C
Drugs; 1996; 51 Suppl 1():20-30. PubMed ID: 8724813
[TBL] [Abstract][Full Text] [Related]
5. The streptogramin antibiotics: update on their mechanism of action.
Beyer D; Pepper K
Expert Opin Investig Drugs; 1998 Apr; 7(4):591-9. PubMed ID: 15991995
[TBL] [Abstract][Full Text] [Related]
6. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.
Harms JM; Schlünzen F; Fucini P; Bartels H; Yonath A
BMC Biol; 2004 Apr; 2():4. PubMed ID: 15059283
[TBL] [Abstract][Full Text] [Related]
7. Streptogramins: a new class of antibiotics.
Khosla R; Verma DD; Kapur A; Aruna RV; Khanna N
Indian J Med Sci; 1999 Mar; 53(3):111-9. PubMed ID: 10798011
[TBL] [Abstract][Full Text] [Related]
8. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
Bozdogan B; Leclercq R
Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
[TBL] [Abstract][Full Text] [Related]
9. Streptogramins. A unique class of antibiotics.
Pechère JC
Drugs; 1996; 51 Suppl 1():13-9. PubMed ID: 8724812
[TBL] [Abstract][Full Text] [Related]
10. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
Lamb HM; Figgitt DP; Faulds D
Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein synthesis by streptogramins and related antibiotics.
Cocito C; Di Giambattista M; Nyssen E; Vannuffel P
J Antimicrob Chemother; 1997 May; 39 Suppl A():7-13. PubMed ID: 9511056
[TBL] [Abstract][Full Text] [Related]
12. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
Fantin B; Leclercq R; Garry L; Carbon C
Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of streptogramin resistance in enterococci.
Werner G; Klare I; Witte W
Int J Med Microbiol; 2002 Jul; 292(2):81-94. PubMed ID: 12195739
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin.
Bouanchaud DH
J Antimicrob Chemother; 1997 May; 39 Suppl A():15-21. PubMed ID: 9511057
[TBL] [Abstract][Full Text] [Related]
15. Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.
Dupuis M; Leclercq R
Antimicrob Agents Chemother; 2006 Jan; 50(1):237-42. PubMed ID: 16377692
[TBL] [Abstract][Full Text] [Related]
16. Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.
Griswold MW; Lomaestro BM; Briceland LL
Am J Health Syst Pharm; 1996 Sep; 53(17):2045-53. PubMed ID: 8870891
[TBL] [Abstract][Full Text] [Related]
17. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
[TBL] [Abstract][Full Text] [Related]
18. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci.
Lina G; Quaglia A; Reverdy ME; Leclercq R; Vandenesch F; Etienne J
Antimicrob Agents Chemother; 1999 May; 43(5):1062-6. PubMed ID: 10223914
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
Hill RL; Smith CT; Seyed-Akhavani M; Casewell MW
J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions.
Isogai N; Urushibara N; Kawaguchiya M; Ghosh S; Suzaki K; Watanabe N; Quiñones D; Kobayashi N
Microb Drug Resist; 2013 Aug; 19(4):298-307. PubMed ID: 23442208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
